Characteristics of Various Factor VIII Concentrates used in Treatment of Haemophilia A
- 1 December 1977
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 37 (4), 543-557
- https://doi.org/10.1111/j.1365-2141.1977.tb01028.x
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Survival of Transfused Factor VIII in Hemophilic Patients Treated with Epsilon Aminocaproic AcidTransfusion, 1976
- Molecular Immunology of Factor VIIIAnnual Review of Medicine, 1974
- Factor 8 concentrates in outpatient therapyPublished by American Medical Association (AMA) ,1972
- The use of facoor VIII and factor IX concentrates during surgeryPublished by American Medical Association (AMA) ,1970
- The in vivo Longevity of Antihaemophilic Factor (Factor VIII)British Journal of Haematology, 1964
- v. Willebrand's Disease in Sweden.Acta Medica Scandinavica, 1959
- Observations on Plasma Banking and Transfusion Procedures for Haemophihc Patients using a Quantitative Assay for Antihaemophilic Globulin (AHG)*British Journal of Haematology, 1959
- Treatment of Hemophilia A with Human Antihemophilic GlobulinActa Medica Scandinavica, 1958
- A CONCENTRATE OF HUMAN ANTIHÆMOPHILIC FACTOR: ITS USE IN SIX CASES OF HÆMOPHILIAThe Lancet, 1957
- On an Inherited Autosomal Hemorrhagic Diathesis with Antihemophilic Globulin (AHG) Deficiency and Prolonged Bleeding Times1Acta Medica Scandinavica, 1957